Kurt Diebold

502 total citations
5 papers, 42 citations indexed

About

Kurt Diebold is a scholar working on Cancer Research, Oncology and Hematology. According to data from OpenAlex, Kurt Diebold has authored 5 papers receiving a total of 42 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Cancer Research, 2 papers in Oncology and 2 papers in Hematology. Recurrent topics in Kurt Diebold's work include Breast Cancer Treatment Studies (3 papers), HER2/EGFR in Cancer Research (2 papers) and Blood groups and transfusion (2 papers). Kurt Diebold is often cited by papers focused on Breast Cancer Treatment Studies (3 papers), HER2/EGFR in Cancer Research (2 papers) and Blood groups and transfusion (2 papers). Kurt Diebold collaborates with scholars based in Germany and Switzerland. Kurt Diebold's co-authors include Jens Huober, Gϋnter von Minckwitz, Iris Schrader, Stephan Henschen, Hans Tesch, Sibylle Loibl, Christine Solbach, Silvia Darb‐Esfahani, Michael Clemens and Katharina Tiemann and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Breast Cancer Research and Treatment.

In The Last Decade

Kurt Diebold

5 papers receiving 41 citations

Peers

Kurt Diebold
Comparison fields: 5 of 18
  • Cancer Research 33
  • Oncology 27
  • Pathology and Forensic Medicine 15
  • Radiology, Nuclear Medicine and Imaging 8
  • Molecular Biology 5
Replace H. Amash with:
H. Amash Italy
Helle Kristine Skjerven Norway
D. Manfreda Austria
M. Untch Germany
Elisabetta Cretella Italy
K. Enomoto Japan
Shivam Mathura United States
Ya-Xin Zhao China
Dennis Slamon United States
R. Pedersini Italy
H. Amash Italy View profile →
Citations per field, relative to Kurt Diebold
Kurt Diebold · 1×
Citations per year, relative to Kurt Diebold
Kurt Diebold · 1×

Countries citing papers authored by Kurt Diebold

Since Specialization
Citations

This map shows the geographic impact of Kurt Diebold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt Diebold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt Diebold more than expected).

Fields of papers citing papers by Kurt Diebold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kurt Diebold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt Diebold. The network helps show where Kurt Diebold may publish in the future.

Co-authorship network of co-authors of Kurt Diebold

This figure shows the co-authorship network connecting the top 25 collaborators of Kurt Diebold. A scholar is included among the top collaborators of Kurt Diebold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kurt Diebold. Kurt Diebold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
# Work Indexed citations
1 1
2 35
3 2
4 3
5
[ABO blood-groups and Rh factor in psychical disorders].
1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026